Viewing Study NCT04338620


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-01-28 @ 5:00 PM
Study NCT ID: NCT04338620
Status: UNKNOWN
Last Update Posted: 2023-03-06
First Post: 2020-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC
Sponsor:
Organization: